Editorials |
From the Division of Vascular Surgery, Brigham and Womens Hospital and Harvard Medical School, Boston, Mass.
Correspondence to Raouf A Khalil, MD, PhD, Harvard Medical School, Brigham and Womens Hospital, Division of Vascular Surgery, NRB 435, 77 Ave Louis Pasteur, Boston, MA 02115. E-mail raouf_khalil@hms.harvard.edu
See related article, pages 12731281
Key Words: calcium calmodulin cell cycle cyclins vascular smooth muscle
An extract of the first 250 words of the full text is provided, because this article has no abstract. |
| Introduction |
|---|
, phospholipase C, protein kinase C and phosphodiesterase.68 An increase in [Ca2+]i could also modulate plasma membrane channels and pumps such as Ca2+-activated K+ channels and the plasma membrane CaATPase (PMCA).9,10 Additionally, Ca2+ may affect sarcoplasmic reticulum channels and pumps such as the inositol 1,4,5-trisphosphate (IP3) receptor, the ryanodine-sensitive receptor and intracellular Ca2+ release channels, and the Ca2+ uptake pump (SERCA).11,12
| |||||||||||
Related Article:
Circ. Res. 2006 98: 1273-1281.
This article has been cited by other articles:
![]() |
T. Afroze, A. M. Sadi, M. A. Momen, S. Gu, S. Heximer, and M. Husain c-Myb-Dependent Inositol 1,4,5-Trisphosphate Receptor Type-1 Expression in Vascular Smooth Muscle Cells Arterioscler Thromb Vasc Biol, June 1, 2007; 27(6): 1305 - 1311. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2006 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |